XML 24 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended
Apr. 01, 2012
Apr. 03, 2011
Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]    
Revenues $ 27,501 $ 27,915
Cost of products sold 20,908 23,501
Gross profit 6,593 4,414
Operating expenses:    
Research and development (including $65 and $78, respectively, of amortization of intangible assets) 2,139 2,505
Selling, general, and administrative (including $60 and $79, respectively, of amortization of intangible assets) 5,743 5,845
Total operating expenses 7,882 8,350
Operating income (loss) (1,289) (3,936)
Other income (expense):    
Interest income 1 1
Interest expense (104) (156)
Miscellaneous 52 299
Income (loss) from continuing operations before income taxes (1,340) (3,792)
Income tax provision-current 79 4
Income tax provision-deferred 12 54
Total income taxes provision 91 58
Net income (loss) from continuing operations (1,431) (3,850)
Discontinued operations:    
Income (loss) from discontinued operations, net of tax (71) (1,853)
Net income (loss) (1,502) (5,703)
Net (income) loss attributable to noncontrolling interest   13
Net income (loss) attributable to Ultralife (1,502) (5,690)
Other comprehensive income (loss):    
Foreign currency translation adjustments 148 227
Comprehensive income (loss) attributable to Ultralife $ (1,354) $ (5,463)
Net income (loss) attributable to Ultralife common shareholders - basic    
Continuing operations $ (0.08) $ (0.22)
Discontinued operations $ (0.01) $ (0.11)
Total $ (0.09) $ (0.33)
Net income (loss) attributable to Ultralife common shareholders - diluted    
Continuing operations $ (0.08) $ (0.22)
Discontinued operations $ (0.01) $ (0.11)
Total $ (0.09) $ (0.33)
Weighted average shares outstanding - basic 17,358 17,276
Weighted average shares outstanding - diluted 17,358 17,276